Barclays
GNLX icon

Barclays’s Genelux GNLX Stock Holding History

Barclays’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.3K Sell
32,756
-49,848
-60% -$136K ﹤0.01% 4130
2025
Q4 		$360K Buy
+82,604
New +$446K ﹤0.01% 4037
2024
Q3 		– Sell
-15,138
Closed -$29.5K – 5359
2024
Q2 		$29.5K Buy
15,138
+1,710
+13% +$5.81K ﹤0.01% 4363
2024
Q1 		$86.3K Sell
13,428
-12,037
-47% -$109K ﹤0.01% 4480
2023
Q4 		$357K Buy
25,465
+22,081
+653% +$349K ﹤0.01% 4097
2023
Q3 		$82.9K Buy
3,384
+2,835
+516% +$71.8K ﹤0.01% 3665
2023
Q2 		$18K Sell
549
-32,629
-98% -$918K ﹤0.01% 4151
2023
Q1 		$920K Buy
+33,178
New +$538K ﹤0.01% 2792

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays's GNLX Position: Q1 2026 in Review

Barclays reduced its Genelux (GNLX) stake by 60% in Q1 2026, selling an estimated $136K and leaving 32,756 shares worth $79.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4130.

Barclays first reported a position in GNLX in Q1 2023 and has held it in 8 quarters since. The position peaked at $920K in Q1 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Barclays held 32,756 shares of Genelux worth $79.3K as of Q1 2026.
  • Barclays sold 49,848 Genelux shares in Q1 2026, an estimated $136K.
  • Genelux made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4130 holding.
  • Barclays first reported a position in Genelux in Q1 2023 and has held it in 8 quarters since.
  • Barclays's Genelux position peaked at $920K in Q1 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.